These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 16631152

  • 1. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 2. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2009 Sep; 66(7):365-9. PubMed ID: 20043577
    [Abstract] [Full Text] [Related]

  • 3. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2010 Sep; 67(12):1314-8. PubMed ID: 21591359
    [Abstract] [Full Text] [Related]

  • 4. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 5. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 6. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 7. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 8. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Czygier M, Szmitkowski M.
    Przegl Lek; 2007 May 01; 64(12):987-90. PubMed ID: 18595499
    [Abstract] [Full Text] [Related]

  • 9. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S, Będkowska GE, Szmitkowski M.
    Growth Factors; 2013 Jun 01; 31(3):98-105. PubMed ID: 23688065
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of CA 15-3 tumor marker in the diagnosis of breast cancer. A pilot study.
    Wojtacki J, Dziewulska-Bokiniec A, Skokowski J, Ciesielski D.
    Neoplasma; 1994 Jun 01; 41(4):213-6. PubMed ID: 7935994
    [Abstract] [Full Text] [Related]

  • 11. Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients.
    Lawicki S, Będkowska GE, Gacuta-Szumarska E, Szmitkowski M.
    Growth Factors; 2012 Feb 01; 30(1):29-36. PubMed ID: 22010785
    [Abstract] [Full Text] [Related]

  • 12. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
    Ławicki S, Będkowska GE, Wojtukiewicz M, Szmitkowski M.
    Adv Med Sci; 2013 Feb 01; 58(2):207-15. PubMed ID: 23846151
    [Abstract] [Full Text] [Related]

  • 13. [The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri].
    Ławicki S, Bedkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M.
    Pol Merkur Lekarski; 2010 May 01; 28(167):354-8. PubMed ID: 20568396
    [Abstract] [Full Text] [Related]

  • 14. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec 01; 43(12):931-6. PubMed ID: 19134334
    [Abstract] [Full Text] [Related]

  • 15. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 Dec 01; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 16. [Level of CA 15-3 antigen--a prognostic factor in patients with breast cancer?].
    Wojtacki J, Dziewulska-Bokiniec A, Kowalski DM, Zółtowska A, Ciesielski D, Suszko M.
    Przegl Lek; 1996 Dec 01; 53(11):788-92. PubMed ID: 9173440
    [Abstract] [Full Text] [Related]

  • 17. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S, Głażewska EK, Sobolewska M, Będkowska GE, Szmitkowski M.
    Ann Lab Med; 2016 May 01; 36(3):223-9. PubMed ID: 26915610
    [Abstract] [Full Text] [Related]

  • 18. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M.
    Clin Lab; 2016 Sep 01; 62(9):1661-1669. PubMed ID: 28164586
    [Abstract] [Full Text] [Related]

  • 19. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A, Piscittelli V, Cassese F, Balbi GC, Balbi C, Cardone A.
    Minerva Ginecol; 1999 Sep 01; 51(7-8):261-4. PubMed ID: 10536419
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
    Ławicki S, Czygier M, Bedkowska E, Wojtukiewicz M, Szmitkowski M.
    Pol Arch Med Wewn; 2008 Sep 01; 118(9):464-9. PubMed ID: 18846980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.